Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Runzaozhiyang capsule is an oral traditional Chinese medicine herbal product used primarily for inflammatory skin diseases, especially chronic eczema and atopic dermatitis, and it has also been studied in psoriasis. Published randomized clinical data identify it as an active comparator or investigational therapy for mild-to-moderate chronic eczema and subacute atopic eczema, with reported improvements in EASI and itch scores and a generally tolerable short-term safety profile. Its precise molecular mechanism of action is not defined in the provided sources; instead, it is described as a multi-herb formulation used empirically for antipruritic and anti-inflammatory effects in dermatology. Public sources also show clinical development activity by Tongjitang Chinese Medicines Company and trial activity involving China TCM and Shanghai skin-disease hospitals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on runzaozhiyang capsule.